Fagron NV (FAGR.BR) — the peer cohort
As of 2026-10-15 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Fagron NV ranks 12 of 14 in its cohort on the Closelooknet composite (53/100) — the cohort is led by Halozyme Therapeutics Inc at 75/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| FAGR.BR Fagron NV | 53 | 46 | 54 | 59 | info | 10.1% |
| ROVI.MC Laboratorios Farmaceuticos ROVI | 61 | 28 | 76 | 50 | warn | 32.4% |
| LNTH Lantheus Holdings Inc | 59 | 66 | 73 | 54 | info | 10.6% |
| BHC.TO Bausch Health Companies Inc | 56 | 71 | 70 | 82 | info | 19% |
| KNSA Kiniksa Pharmaceuticals Ltd | 56 | 94 | 57 | 19 | ok | 3.7% |
| GALDY GALDERMA GROUP AG | 55 | 56 | 57 | 25 | info | 10.2% |
| ALKS Alkermes Plc | 51 | 51 | 51 | 23 | info | 28% |
| ARGX.BR Argen-X | 64 | 64 | 75 | 28 | info | 18% |
| UCB.BR UCB SA | 61 | 20 | 70 | 57 | warn | 28.5% |
| TUB.BR Tubize-Fin | 25 | 17 | 18 | 25 | warn | 30.2% |
| HALO Halozyme Therapeutics Inc | 75 | 98 | 94 | 47 | ok | 0.7% |
| DXCM DexCom Inc | 66 | 87 | 80 | 34 | watch | 9.8% |
| ONC BeiGene, Ltd. | 64 | 84 | 63 | 30 | ok | 2.9% |
| LLY Eli Lilly and Company | 64 | 80 | 91 | 27 | bull | 6.5% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-10-15
Quick answers
Who are Fagron NV's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Bausch Health Companies Inc (BHC.TO), Kiniksa Pharmaceuticals Ltd (KNSA), GALDERMA GROUP AG (GALDY), Alkermes Plc (ALKS), Argen-X (ARGX.BR), UCB SA (UCB.BR) and others.
How does FAGR.BR score against its peers?
Fagron NV's composite reads 53/100, ranking 12 of 14 in its cohort as of 2026-10-15; the cohort's highest composite is Halozyme Therapeutics Inc at 75/100. Closelooknet scores are research diary readings, not ratings or advice.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- BHC.TO Bausch Health Companies Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- GALDY GALDERMA GROUP AGindustry
- ALKS Alkermes Plcindustry
- PRGO Perrigo Company PLCindustry
- HCM.L HUTCHMED China Ltdindustry
- VTRS Viatris Incindustry
- UTHR United Therapeutics Corporationindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- ZTS Zoetis Incindustry
- ELAN Elanco Animal Healthindustry
- DMP.DE Dermapharm Holding SEindustry
- ALM.MC Almirall S.A.industry
- NBIX Neurocrine Biosciences Incindustry
- APTX.TO Apotex Health Corpindustry
- ARGX.BR Argen-Xsector
- UCB.BR UCB SAsector
- TUB.BR Tubize-Finsector